GWP
DNA icon

Gen-Wealth Partners’s Ginkgo Bioworks DNA Stock Holding History

Gen-Wealth Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50 Hold
5
– – ﹤0.01% 717
2026
Q1 		$31 Hold
5
– – ﹤0.01% 724
2025
Q4 		$42 Hold
5
– – ﹤0.01% 688
2025
Q3 		$73 Hold
5
– – ﹤0.01% 679
2025
Q2 		$56 Hold
5
– – ﹤0.01% 640
2025
Q1 		$29 Hold
5
– – ﹤0.01% 618
2024
Q4 		$49 Hold
5
– – ﹤0.01% 646
2024
Q3 		$39 Sell
5
-1
-17% -$10 ﹤0.01% 657
2024
Q2 		$77 Hold
6
– – ﹤0.01% 645
2024
Q1 		$268 Buy
+6
New +$311 ﹤0.01% 617

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Gen-Wealth Partners's DNA Position: Q2 2026 in Review

Gen-Wealth Partners held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 5 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #717.

Gen-Wealth Partners first reported a position in DNA in Q1 2024 and has held it in 10 quarters since. The position peaked at $268 in Q1 2024. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Gen-Wealth Partners held 5 shares of Ginkgo Bioworks worth $50 as of Q2 2026.
  • Gen-Wealth Partners left its Ginkgo Bioworks share count unchanged in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Gen-Wealth Partners's portfolio in Q2 2026, its #717 holding.
  • Gen-Wealth Partners first reported a position in Ginkgo Bioworks in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's Ginkgo Bioworks position peaked at $268 in Q1 2024.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.